Sandoz Kicks Off Supreme Court Biosimilar Battle
The Federal Circuit erred by forcing biosimilar makers to win approval before supplying 180-day notice of sales to rivals, Sandoz told the U.S. Supreme Court on Friday, kicking off a showdown...To view the full article, register now.
Already a subscriber? Click here to view full article